H.R. 1660 — 115th Congress
Global Health Innovation Act of 2017
Sponsor
Latest action
Jan 3, 2019Became Public Law No: 115-411.
CRS summary
As of Jan 3, 2019Public Law
Global Health Innovation Act of 2017
This bill directs the U.S. Agency for International Development (USAID) to report to Congress, annually for four years, on the development and use of global health innovations in USAID programs, projects, and activities.
Such reports shall include topics including: (1) USAID's health product development goals and progress towards their achievement; (2) how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases; (3) how USAID, alone and in partnerships, is leveraging U.S. investments to achieve greater health innovation; and (4) coordination with other federal departments.
Congressional Research Service, via api.congress.gov (public domain)
Roll-call votes
1 on recordJan 18, 2018 · On Motion to Suspend the Rules and Pass
Full roll callYea — 423: 230 R · 191 D · 2 I
Nay — 3: 2 R · 1 L
| Member | State |
|---|---|
| Justin Amash | MI |
| Walter B. Jones | NC |
| Louie Gohmert | TX |
Not Voting — 4: 3 R · 1 D
| Member | State |
|---|---|
| Elijah E. Cummings | MD |
| Steve Scalise | LA |
| James B. Renacci | OH |
| Kristi L. Noem | SD |
Member pages currently show roll-call votes from the 119th Congress only. The “Member pages” column marks votes from that congress.